authors
- Karim, S
- Ding, K
- Bradbury, P
- Ellis, Peter
- Mittman, N
- Xiaoqun Sun, X
- Millward, M
- Liu, G
- Sun, S
- Stockler, MR
- Cohen, V
- Blais, N
- Sangha, R
- Boyer, M
- Sasidharan, R
- Lee, C
- Shepherd, FA
- Goss, G
- Seymour, L
- Leighl, NB
Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2017
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal